GF
CLVS

Gabelli Funds’s Clovis Oncology, Inc. CLVS Stock Holding History

Gabelli Funds’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-110,900
Closed -$132K – 1317
2022
Q3 		$132K Sell
110,900
-2,000
-2% -$3.12K ﹤0.01% 1188
2022
Q2 		$203K Sell
112,900
-2,000
-2% -$2.95K ﹤0.01% 1188
2022
Q1 		$232K Buy
114,900
+5,000
+5% +$9.82K ﹤0.01% 1225
2021
Q4 		$298K Hold
109,900
– – ﹤0.01% 1183
2021
Q3 		$490K Buy
109,900
+5,000
+5% +$24.1K ﹤0.01% 1058
2021
Q2 		$608K Buy
104,900
+5,000
+5% +$29.3K ﹤0.01% 1003
2021
Q1 		$701K Sell
99,900
-55,200
-36% -$370K ﹤0.01% 974
2020
Q4 		$744K Buy
155,100
+3,200
+2% +$16.2K 0.01% 937
2020
Q3 		$886K Buy
151,900
+5,500
+4% +$32.9K 0.01% 845
2020
Q2 		$988K Sell
146,400
-3,000
-2% -$22.7K 0.01% 804
2020
Q1 		$950K Buy
149,400
+1,000
+0.7% +$8.02K 0.01% 790
2019
Q4 		$1.55M Hold
148,400
– – 0.01% 770
2019
Q3 		$583K Buy
148,400
+39,500
+36% +$320K ﹤0.01% 938
2019
Q2 		$1.62M Buy
108,900
+64,200
+144% +$1.16M 0.01% 807
2019
Q1 		$1.11M Buy
44,700
+29,800
+200% +$747K 0.01% 858
2018
Q4 		$268K Buy
14,900
+8,000
+116% +$163K ﹤0.01% 1053
2018
Q3 		$203K Buy
6,900
+1,500
+28% +$58.1K ﹤0.01% 1105
2018
Q2 		$246K Sell
5,400
-20,000
-79% -$973K ﹤0.01% 1091
2018
Q1 		$1.34M Buy
25,400
+6,900
+37% +$403K 0.01% 856
2017
Q4 		$1.26M Buy
18,500
+3,100
+20% +$217K 0.01% 867
2017
Q3 		$1.27M Buy
15,400
+6,600
+75% +$523K 0.01% 870
2017
Q2 		$824K Buy
+8,800
New +$538K ﹤0.01% 932

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Gabelli Funds's CLVS Position: Q4 2022 in Review

Gabelli Funds sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 110,900 shares — an estimated $132K sold.

Gabelli Funds first reported a position in CLVS in Q2 2017 and held it in 22 quarters. The position peaked at $1.62M in Q2 2019. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Gabelli Funds reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Gabelli Funds sold 110,900 Clovis Oncology, Inc. shares in Q4 2022, an estimated $132K.
  • Gabelli Funds first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 22 quarters.
  • Gabelli Funds's Clovis Oncology, Inc. position peaked at $1.62M in Q2 2019.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.